Occurrence of Comorbidities before and after Soft Tissue Sarcoma Diagnosis

Table 2

Proportion of patients with comorbidities* 12 months before diagnosis of soft tissue sarcoma, compared to a noncancer population.

Comorbidity	Patients with soft tissue sarcoma (𝑁=533)	Cancer-free control cohort (𝑁=5,330)	Odds ratio
	N (%)	N (%)	(95% CI)
Cardiovascular disease	178 (33)	1,148 (22)	2.0 (1.7–2.5)
Respiratory disease	54 (10)	262 (5)	2.2 (1.6–3.0)
Diabetes	36 (7)	212 (4)	1.8 (1.2–2.6)
Anemia	31 (6)	92 (2)	3.6 (2.4–5.5)
Depression	34 (6)	177 (3)	2.0 (1.4–2.9)

95% CI: 95% confidence interval; *comorbidity defined as either at least 2 dispensings of a relevant drug or a hospitalization for that condition before soft tissue sarcoma diagnosis.